|
Invion repurposes blood pressure drug to target asthma
Australian Life Scientist Invion repurposes blood pressure drug to target asthma. Nadolol is known for its role in treating blood pressure, but now Invion is conducting a phase II trial to assess its effects on asthma and chronic bronchitis. Tim Dean (Australian Life Scientist … |
View full post on asthma – Google News